Clinical Frailty Scale (CFS) reliably stratifies octogenarians in German ICUs: a multicentre prospective cohort study

Very old patients (age ≥ 80 years) now comprise approximately one fourth of all intensive care unit (ICU) admissions in the United States and similarly in Europe, receive much more intensive medical treatment than in the past, and progressively survive even fatal critical illnesses [1, 2]. However, in view of enormous personal efforts of intensive care givers and increased economic costs due to prolonged and complicated ICU stays of octogenarians, proportionality of costs and resource usage came in focus [2] with two main aspects: First, emergency triage process must be optimised and simplified to facilitate ICU admission for very old patients [3, 4]. Second, more scientific and clinical interest must be applied on all aspects of geriatric medicine to adapt existing risk-stratification data to daily clinical scenarios [5, 6].

In this context, a 9-point Clinical Frailty Scale (CFS) as an advancement of the Canadian 7-point CFS has been developed [7]. Recently, the prospective, observational, European-ICU-network based VIP-1 study demonstrated that frailty is a significant factor reducing 30-day survival and that the 9-point CFS is an appropriate tool to assess this effect [4]. The rationale behind scientific efforts in this field is explained by the very complex nature of circumscribing frailty to other specific medical problems [8]. Consecutively, whereas physical frailty is a measurable clinical phenotype of increased vulnerability for developing adverse outcomes (e.g. disability and/or mortality) when exposed to a stressor, it is highly difficult to explain the current frailty status in an abbreviated and objective manner to another medical-professional.

As the largest study investigating the value of preadmission CFS in elderlies admitted to ICUs, the VIP-1 study was one of the first large studies highlighting the impact of assessing CFS as a herald for outcome in very old ICU patients [4]. The advanced 9-point CFS, measured at a rapid diagnostic glance, showed even more robust outcome-foreshowing value compared to routinely used ICU indices like SOFA or APACHE-II score in VIP-1 [4].

ICUs from 21 European countries and 3 Non-Europe countries participated in the VIP-1 study [4]. The participating countries represent a broad range of different health care systems and philosophies, and less than 10% of included patients came from Germany. The recent Organisation for Economic Co-operation and Development (OECD) health report emphasized the differences in health status and life expectancy in the participating countries, leading to varying challenges [9]. These factors most likely affect case mixes and intensity of treatment provided in ICUs of the different countries participating in the VIP-1 trial. Indeed, VIP-1 showed regional differences in the frequency of frail patients admitted to ICUs. Consequently, the conclusions drawn by the multi-national VIP-1 study might not be transferable to the individual health care situation of each participating country. In this current study, we undertook a multicentre sub-analysis of the German VIP-1 cohort and aimed to test if the predictive value of CFS is still robust on a national level in very diversified and high-tech German ICUs.

In this sub-analysis of the European VIP-1 study cohort, a total number of 308 patients of 80 years of age or older admitted to 20 German ICUs were analysed. Participating ICUs collected data from 3 to 20 patients (Fig. 1).

Median age was 84 [IQR 82–87] years and 50% of the patients were male. Median LOS in the ICU was 3.1 [IQR 1.1–8.1] days. ICU-mortality was 17.3% and 30-day mortality was 31.2% (Table 1). Out of the analysed ICU patients, 31.5% had planned admissions due to post surgery care. The other patients were admitted due to acute medical reasons (52.6%), trauma (10.7%) or acute surgery (5.2%) as shown in Table 1 and Fig. 2. Respiratory and/or circulatory failure was the most frequent cause for admission. Use of life sustaining treatments is shown in Table 1. In 26.6% of the patients none of the ICU procedures were recorded. Frailty according to the CFS could be determined for all patients.

Frailty status	Overall	Not frail (CFS 1–4)	Frail (CFS 5–9)	p-value
Number of admissions	308 (100%)	143 (46.4%)	165 (53.6%)
Age	84 [82–87]	82 [81–86]	85 [82–88]	< 0.001
Male	164 (50%)	79 (55.2%)	75 (45.5%)	0.09
APACHE II	18 [12–26]	15 [12–25]	19 [12–26]	0.18
SAPS II	39 [29.5–51]	37 [29–48]	42 [30–55]	0.17
SOFA Score	6 [3–10]	6 [3–9]	7 [4–10]	0.016
Cause of admission
Acute medical	162 (52.6%)	58 (40.6%)	104 (63%)	< 0.001
Acute surgery	16 (5.2%)	8 (5.6%)	8 (4.8%)	0.77
Trauma	33 (10.7%)	14 (9.8%)	19 (11.5%)	0.63
Elective surgery	97 (31.5%)	63 (44.1%)	34 (20.6%)	< 0.001
ICU length of stay (days)	3.1 [1.1–8.1]	2.9 [1–7]	3.4 [1.4–9.5]	0.21
Use of life sustaining treatments
Non-invasive ventilation	104 (33.8%)	48 (33.6%)	56 (33.9%)	0.95
Mechanical ventilation	141 (45.8%)	59 (41.3%)	82 (49.7%)	0.14
Vasoactive drugs	189 (61.4%)	82 (57.3%)	107 (64.8%)	0.18
Renal replacement therapy	59 (19.2%)	26 (18.2%)	33 (20%)	0.69
Treatment withheld	41 (13.3%)	11 (7.7%)	30 (18.2%)	0.01
Treatment withdrawn	36 (11.7%)	10 (7%)	26 (15.8%)	0.02
ICU mortality	53 (17.3%)	16 (11.3%)	37 (22.4%)	0.01
30-day mortality	84 (31.2%)	23 (18.4%)	61 (42.4%)	< 0.001

Frail patients are characterized by frailty score ≥ 5 and not frail patients by a frailty score ≤ 4. Data are presented as median and interquartile range [IQR] or frequency and percentages (n, %). ICU: Intensive Care Unit. CFS: Clinical Frailty Score ranging from 1 (not frail) to 9 (terminally ill).

Impact of the different factors on 30-day mortality in a univariate model is presented in the left part of the table. Factors with a p-value below 0.10 in a univariate logistic regression analysis were included into the multivariate model shown in the right part of the table. Impact of the factors on 30-day mortality is presented as Odd’s Ratio (OR) in the univariate model or as adjusted Odd’s Ratio (AOR) in the multivariate model respectively, and 95% Confidence Interval (95% CI). CFS: Clinical Frailty Score ranging from 1 (not frail) to 9 (terminally ill).

This multicentre analysis of the German VIP-1 cohort [4] focussing on a large cohort of more than 300 very old patients admitted to 20 German ICUs showed that frailty measured by the 9-point CFS [4] is a valuable predictor of ICU- and 30-day mortality for very old patients admitted to highly diversified and high-tech German ICUs. These findings complement the recent analyses of the multi-national, prospective European VIP-1 cohort [4]. In previous publications, conducted mainly in single centres, huge differences of ICU survival rates among octogenarians ranging from 14 to 46% have been described [13, 14]. This divergence can most likely be explained by case mix differences. Thus, the multi-national European VIP-1 study showed that in central, northern and eastern Europe a higher percentage of the admitted patients were frailer than in southern and western European countries [4]. This finding is also reflected by the recent OECD health report pointing out differences in health care systems in the OECD countries [9]. Our analysis of very old patients in German ICUs showed an ICU mortality of 17.3% and a 30-day mortality of 31.2% similar to the multi-national VIP-1 cohort with 22.1 and 32.4% and to a Canadian cohort with 21.8 and 35% [15], respectively. However, despite high mortality rates, it is difficult to identify patients at risk among that vulnerable cohort since commonly used scoring systems for prediction of ICU outcome were developed for younger cohorts and are not reliable for use in the very old [16]. Thus, in contrast to the results of the multi-national VIP-1 cohort, APACHE II, SAPS II and the SOFA score failed to predict 30-day mortality in a multivariate regression analysis on our multicentre cohort of very old patients in German ICUs. Recently, it was suggested that frailty is correlated with mortality in very old patients and that quantification of frailty might predict the outcome of very old patients admitted to ICUs. Frailty is defined as a condition of clinical vulnerability associated with age dependent reduction of physiological reserves [17]. Different scores for the assessment of frailty were developed and their ability for the prediction of adverse outcomes including decline in functional performance, prolonged length of stay, institutionalisation, and mortality in geriatric patient collectives was confirmed [4, 18–22]. Using the previously reported 9-point CFS [4], we could show that increased frailty was independently associated with intra-ICU and 30-day mortality in a multicentre cohort of very old patients admitted to German ICUs. Thus, our data confirmed the observations of previous studies from Europe [4] and America [23] and proofed the usability of the CFS for risk stratification of octogenarians in German ICUs. The only parameter that was stronger associated with 30-day mortality than the frailty status was the type of admission (planned vs. unplanned). That observation might be caused by a selection bias since our analyses revealed that electively admitted patients were less frail and showed lower APACHE II, SAPS II and SOFA scores. Furthermore, health status of patients selected for elective surgery could be optimized prior to ICU admission. In contrast to the analysis of the multi-national European VIP-1 cohort [4], our sub-analysis of the German VIP-1 cohort revealed no independent impact of age, gender or the SOFA score on 30-day mortality in a multivariate regression analysis. This important difference between the multi-national VIP-1 cohort comprising patients treated in different healthcare systems with diverging philosophies and financial resources and our more homogeneous German sub-cohort is most likely caused by the above mentioned inhomogeneity of the multi-national cohort. Thus, in contrast to the analysis of the multi-national VIP-1 cohort, our analysis among very old patients admitted to German ICUs showed that in octogenarians and nonagenarians not chronologic age but the bioenergetics state, stratified by the CFS, is a strong predictor of mortality.

The strengths of our study include its prospective multicentre character and the relatively high number of included patients. Time dependent confounders were minimized by limiting recruiting time to 8 months, thus time dependent confounders could be minimalized.

However, this study has limitations. No data on the proportion of included patients in relation to all ICU admissions nor data on patients that were not admitted to ICU due to triage decisions were recorded. For the sake of feasibility, neither long-term survival nor the functional status of the patients after ICU discharge were assessed. The used 9-point frailty scale is subjective with potentially high inter-rater variability. Nonetheless, in the context of acute ICU admission of vulnerable patients it is likely to be more feasible and easier to access than more objective scoring systems.

In conclusion, the CFS is an easy determinable valuable tool for the prediction of mortality in very old patients, thus it can facilitate decision making for intensive care givers in Germany.